A phase 2, open-label, safety and efficacy study of telotristat ethyl plus first-line chemotherapy in patients with advanced biliary tract cancer.
| Autor: | Kim, Richard D., Joseph-Ridge, Nancy, Du, Jichang, North, Janine, Warren, Cathy, Iyer, Renuka V. |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p472-472, 151p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|